Ursa supply price to rise by 10%

Published: 2009-03-26 06:57:00

Updated: 2009-03-26 06:57:00

Daewoong Pharm says its flagship product Ursa will rise by 8 to 10 percent from next month due to pressure stemming from falling Korean currency and rising raw material costs.

"Our price was set when the exchange rate was 930 won against a dollar. Now that the exchange rate has jumped up almos...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK